Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Caleres
CAL
$419M
| $3.16M | ﹤0.01% |
+142,175
| New | +$3.43M |
|
3352
Tradeweb Markets
TW
$23B
| $3.15M | ﹤0.01% |
39,010
-144,365
| -79% | -$12.5M |
|
3353
Carpenter Technology
CRS
$23.6B
| $3.15M | ﹤0.01% |
96,169
-31,980
| -25% | -$1.13M |
|
3354
CALL
T. Rowe Price
TROW
$23.7B
| $3.15M | ﹤0.01% |
+16,000
| New | +$3.37M |
|
|
3355
PUT
T. Rowe Price
TROW
$23.7B
| $3.15M | ﹤0.01% |
+16,000
| New | +$3.37M |
|
|
AYX
3356
DELISTED
Alteryx Inc
AYX
| $3.14M | ﹤0.01% |
42,990
+40,642
| +1,731% | +$3.06M |
|
3357
Verastem
VSTM
$654M
| $3.14M | ﹤0.01% |
84,918
-31,847
| -27% | -$1.17M |
|
3358
Vanguard Total International Bond ETF
BNDX
$82.5B
| $3.14M | ﹤0.01% |
+55,076
| New | +$3.17M |
|
3359
CALL
Sempra
SRE
$55.1B
| $3.14M | ﹤0.01% |
+49,600
| New | +$3.27M |
|
|
3360
T. Rowe Price
TROW
$23.7B
| $3.14M | ﹤0.01% |
15,947
-3,122
| -16% | -$657K |
|
3361
Aterian
ATER
$7.03M
| $3.13M | ﹤0.01% |
24,103
+10,790
| +81% | +$1.2M |
|
|
HUT
3362
Hut 8
HUT
$9.79B
| $3.13M | ﹤0.01% |
+74,557
| New | +$2.48M |
|
|
LOKM.U
3363
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
| $3.13M | ﹤0.01% |
316,000
-41,068
| -12% | -$409K |
|
3364
BlackBerry
BB
$4.78B
| $3.13M | ﹤0.01% |
321,792
-298,352
| -48% | -$3.13M |
|
3365
PUT
TripAdvisor
TRIP
$1.16B
| $3.13M | ﹤0.01% |
+92,500
| New | +$3.32M |
|
3366
CGI
GIB
$15.5B
| $3.12M | ﹤0.01% |
+36,743
| New | +$3.3M |
|
3367
Cabot Corp
CBT
$4.32B
| $3.12M | ﹤0.01% |
62,272
-110,196
| -64% | -$5.89M |
|
|
SBEAU
3368
DELISTED
SilverBox Engaged Merger Corp I Units
SBEAU
| $3.12M | ﹤0.01% |
314,333
-332,096
| -51% | -$3.3M |
|
3369
Bilibili
BILI
$6.95B
| $3.12M | ﹤0.01% |
47,088
-32,716
| -41% | -$2.8M |
|
|
ISPO
3370
DELISTED
Inspirato
ISPO
| $3.12M | ﹤0.01% |
15,408
+13,147
| +581% | +$2.64M |
|
|
CNVY
3371
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $3.11M | ﹤0.01% |
370,622
-12,921
| -3% | -$115K |
|
3372
Digi International
DGII
$2.88B
| $3.11M | ﹤0.01% |
147,812
+16,314
| +12% | +$338K |
|
|
DAO
3373
Youdao
DAO
$2.01B
| $3.1M | ﹤0.01% |
256,833
+201,849
| +367% | +$2.75M |
|
3374
Donnelley Financial Solutions
DFIN
$1.19B
| $3.1M | ﹤0.01% |
89,661
+38,133
| +74% | +$1.26M |
|
|
SKYAU
3375
DELISTED
Skydeck Acquisition Corp. Units
SKYAU
| $3.1M | ﹤0.01% |
311,638
-105,780
| -25% | -$1.05M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.